Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Vaccinex, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 2.58M | 1.60M | −979.7K (−37.9%) |
| Value | $2.92M | $1.07M | −$1.85M (−63.5%) |
New holders (4)
Institutions that held Vaccinex, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 32,100 | $21.0K | 0.00% |
| Two Sigma Investments, LP | 16,159 | $10.7K | 0.00% |
| XTX Topco Ltd | 11,737 | $7.80K | 0.00% |
| Financial Connections Group, Inc. | 270 | $0 | 0.00% |
Sold out (5)
Institutions that held Vaccinex, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Armistice Capital, LLC | 680,000 | $768.4K |
| Millennium Management LLC | 13,757 | $15.5K |
| Tacita Capital Inc | 3,172 | $3.55K |
| BlackRock Inc. | 172 | $194 |
| Simplex Trading, LLC | 54 | $0 |